ABO blood group as a determinant of COVID-19 and Long COVID: An observational, longitudinal, large study
An association of ABO blood group and COVID-19 remains controversial. Following STROBE guidance for observational research, we explored the distribution of ABO blood group in patients hospitalized for acute COVID-19 and in those with Long COVID. Contingency tables were made and risk factors were exp...
Gespeichert in:
| Veröffentlicht in: | PloS one 2023-06, Vol.18 (6), p.e0286769-e0286769 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e0286769 |
|---|---|
| container_issue | 6 |
| container_start_page | e0286769 |
| container_title | PloS one |
| container_volume | 18 |
| creator | Soriano, Joan B Peláez, Adrián Busquets, Xavier Rodrigo-García, María Pérez-Urría, Elena Ávalos Alonso, Tamara Girón, Rosa Valenzuela, Claudia Marcos, Celeste García-Castillo, Elena Ancochea, Julio |
| description | An association of ABO blood group and COVID-19 remains controversial.
Following STROBE guidance for observational research, we explored the distribution of ABO blood group in patients hospitalized for acute COVID-19 and in those with Long COVID. Contingency tables were made and risk factors were explored using crude and adjusted Mantle-Haentzel odds ratios (OR and 95% CI).
Up to September 2022, there were a total of 5,832 acute COVID-19 hospitalizations in our hospital, corresponding to 5,503 individual patients, of whom blood group determination was available for 1,513 (27.5%). Their distribution by ABO was: 653 (43.2%) group 0, 690 (45.6%) A, 113 (7.5%) B, and 57 (3.8%) AB, which corresponds to the expected frequencies in the general population. In parallel, of 676 patients with Long COVID, blood group determination was available for 135 (20.0%). Their distribution was: 60 (44.4%) from group 0, 61 (45.2%) A, 9 (6.7%) B, and 5 (3.7%) AB. The distribution of the ABO system of Long COVID patients did not show significant differences with respect to that of the total group (p ≥ 0.843). In a multivariate analysis adjusting for age, sex, ethnicity, and severity of acute COVID-19 infection, subgroups A, AB, and B were not significantly associated with developing Long COVID with an OR of 1.015 [0.669-1.541], 1.327 [0.490-3.594] and 0.965 [0.453-2.058], respectively. The effect of the Rh+ factor was also not significant 1,423 [0.772-2,622] regarding Long COVID.
No association of any ABO blood subgroup with COVID-19 or developing Long COVID was identified. |
| doi_str_mv | 10.1371/journal.pone.0286769 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2821938221</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A751520067</galeid><doaj_id>oai_doaj_org_article_706e9c97f88642ff9cdd613d3bc1dd32</doaj_id><sourcerecordid>A751520067</sourcerecordid><originalsourceid>FETCH-LOGICAL-c693t-227e66318e0c30356304235daaf4fbc725071ffa18a11169e9dbb79713e690603</originalsourceid><addsrcrecordid>eNqNk1tr2zAUx83YWLtu32BsgsLoYMl0sSVrLyPNboFAYJe-ClkXR8GxMsku67ef0rglHn0YepB09Dt_nXOkk2UvEZwiwtD7je9DK5vpzrdmCnFJGeWPslPECZ5QDMnjo_VJ9izGDYQFKSl9mp0QhinLITrN1rPLFaga7zWog-93QEYggTadCVvXyrYD3oL56mrxaYI4kK0GS9_WB8sHMGuBr6IJ17JzPgXzDjTp1HW9doedDLUBMe1vnmdPrGyieTHMZ9mvL59_zr9Nlquvi_lsOVGUk26CMTOUElQaqAgkBSUwx6TQUtrcVorhAjJkrUSlRAhRbriuKsYZIoZySCE5y14fdHeNj2IoUhS4xKkaJcYoEYsDob3ciF1wWxluhJdO3Bp8qIUMnVONEQxSwxVntixpjq3lSmuKiCaVQloTnLQ-Drf11dZoZdouyGYkOj5p3VrU_logiAnLOUkKF4NC8L97EzuxdVGZppGt8f1t4IlklOzR83_Qh9MbqFqmDFxrfbpY7UXFjBWowBBSlqjpA1Qa2mydSl_KumQfObwdOSSmM3-6WvYxisWP7__Prq7G7Jsjdm1k062jb_r9h4pjMD-AKvgYg7H3VUZQ7Dvirhpi3xFi6Ijk9ur4he6d7lqA_AXfFQJZ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2821938221</pqid></control><display><type>article</type><title>ABO blood group as a determinant of COVID-19 and Long COVID: An observational, longitudinal, large study</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Public Library of Science (PLoS)</source><creator>Soriano, Joan B ; Peláez, Adrián ; Busquets, Xavier ; Rodrigo-García, María ; Pérez-Urría, Elena Ávalos ; Alonso, Tamara ; Girón, Rosa ; Valenzuela, Claudia ; Marcos, Celeste ; García-Castillo, Elena ; Ancochea, Julio</creator><creatorcontrib>Soriano, Joan B ; Peláez, Adrián ; Busquets, Xavier ; Rodrigo-García, María ; Pérez-Urría, Elena Ávalos ; Alonso, Tamara ; Girón, Rosa ; Valenzuela, Claudia ; Marcos, Celeste ; García-Castillo, Elena ; Ancochea, Julio</creatorcontrib><description>An association of ABO blood group and COVID-19 remains controversial.
Following STROBE guidance for observational research, we explored the distribution of ABO blood group in patients hospitalized for acute COVID-19 and in those with Long COVID. Contingency tables were made and risk factors were explored using crude and adjusted Mantle-Haentzel odds ratios (OR and 95% CI).
Up to September 2022, there were a total of 5,832 acute COVID-19 hospitalizations in our hospital, corresponding to 5,503 individual patients, of whom blood group determination was available for 1,513 (27.5%). Their distribution by ABO was: 653 (43.2%) group 0, 690 (45.6%) A, 113 (7.5%) B, and 57 (3.8%) AB, which corresponds to the expected frequencies in the general population. In parallel, of 676 patients with Long COVID, blood group determination was available for 135 (20.0%). Their distribution was: 60 (44.4%) from group 0, 61 (45.2%) A, 9 (6.7%) B, and 5 (3.7%) AB. The distribution of the ABO system of Long COVID patients did not show significant differences with respect to that of the total group (p ≥ 0.843). In a multivariate analysis adjusting for age, sex, ethnicity, and severity of acute COVID-19 infection, subgroups A, AB, and B were not significantly associated with developing Long COVID with an OR of 1.015 [0.669-1.541], 1.327 [0.490-3.594] and 0.965 [0.453-2.058], respectively. The effect of the Rh+ factor was also not significant 1,423 [0.772-2,622] regarding Long COVID.
No association of any ABO blood subgroup with COVID-19 or developing Long COVID was identified.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0286769</identifier><identifier>PMID: 37267401</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>ABO Blood-Group System ; ABO system ; Antibodies ; Antigens ; Biology and Life Sciences ; Blood ; Blood groups ; Clinical outcomes ; Contingency ; COVID-19 ; COVID-19 - epidemiology ; Health aspects ; Health risks ; Hospitalization ; Humans ; Infections ; Long COVID ; Longitudinal Studies ; Medicine and Health Sciences ; Minority & ethnic groups ; Multivariate analysis ; Pandemics ; Physical Sciences ; Post-Acute COVID-19 Syndrome ; Proteins ; Research and Analysis Methods ; Rh-Hr Blood-Group System ; Risk Factors ; Severe acute respiratory syndrome coronavirus 2 ; Subgroups ; Viral infections</subject><ispartof>PloS one, 2023-06, Vol.18 (6), p.e0286769-e0286769</ispartof><rights>Copyright: © 2023 Soriano et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</rights><rights>COPYRIGHT 2023 Public Library of Science</rights><rights>2023 Soriano et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 Soriano et al 2023 Soriano et al</rights><rights>2023 Soriano et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c693t-227e66318e0c30356304235daaf4fbc725071ffa18a11169e9dbb79713e690603</citedby><cites>FETCH-LOGICAL-c693t-227e66318e0c30356304235daaf4fbc725071ffa18a11169e9dbb79713e690603</cites><orcidid>0000-0002-9988-4605 ; 0000-0002-4190-6533 ; 0000-0003-0284-6643 ; 0000-0001-9740-2994</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237493/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237493/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79343,79344</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37267401$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Soriano, Joan B</creatorcontrib><creatorcontrib>Peláez, Adrián</creatorcontrib><creatorcontrib>Busquets, Xavier</creatorcontrib><creatorcontrib>Rodrigo-García, María</creatorcontrib><creatorcontrib>Pérez-Urría, Elena Ávalos</creatorcontrib><creatorcontrib>Alonso, Tamara</creatorcontrib><creatorcontrib>Girón, Rosa</creatorcontrib><creatorcontrib>Valenzuela, Claudia</creatorcontrib><creatorcontrib>Marcos, Celeste</creatorcontrib><creatorcontrib>García-Castillo, Elena</creatorcontrib><creatorcontrib>Ancochea, Julio</creatorcontrib><title>ABO blood group as a determinant of COVID-19 and Long COVID: An observational, longitudinal, large study</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>An association of ABO blood group and COVID-19 remains controversial.
Following STROBE guidance for observational research, we explored the distribution of ABO blood group in patients hospitalized for acute COVID-19 and in those with Long COVID. Contingency tables were made and risk factors were explored using crude and adjusted Mantle-Haentzel odds ratios (OR and 95% CI).
Up to September 2022, there were a total of 5,832 acute COVID-19 hospitalizations in our hospital, corresponding to 5,503 individual patients, of whom blood group determination was available for 1,513 (27.5%). Their distribution by ABO was: 653 (43.2%) group 0, 690 (45.6%) A, 113 (7.5%) B, and 57 (3.8%) AB, which corresponds to the expected frequencies in the general population. In parallel, of 676 patients with Long COVID, blood group determination was available for 135 (20.0%). Their distribution was: 60 (44.4%) from group 0, 61 (45.2%) A, 9 (6.7%) B, and 5 (3.7%) AB. The distribution of the ABO system of Long COVID patients did not show significant differences with respect to that of the total group (p ≥ 0.843). In a multivariate analysis adjusting for age, sex, ethnicity, and severity of acute COVID-19 infection, subgroups A, AB, and B were not significantly associated with developing Long COVID with an OR of 1.015 [0.669-1.541], 1.327 [0.490-3.594] and 0.965 [0.453-2.058], respectively. The effect of the Rh+ factor was also not significant 1,423 [0.772-2,622] regarding Long COVID.
No association of any ABO blood subgroup with COVID-19 or developing Long COVID was identified.</description><subject>ABO Blood-Group System</subject><subject>ABO system</subject><subject>Antibodies</subject><subject>Antigens</subject><subject>Biology and Life Sciences</subject><subject>Blood</subject><subject>Blood groups</subject><subject>Clinical outcomes</subject><subject>Contingency</subject><subject>COVID-19</subject><subject>COVID-19 - epidemiology</subject><subject>Health aspects</subject><subject>Health risks</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>Infections</subject><subject>Long COVID</subject><subject>Longitudinal Studies</subject><subject>Medicine and Health Sciences</subject><subject>Minority & ethnic groups</subject><subject>Multivariate analysis</subject><subject>Pandemics</subject><subject>Physical Sciences</subject><subject>Post-Acute COVID-19 Syndrome</subject><subject>Proteins</subject><subject>Research and Analysis Methods</subject><subject>Rh-Hr Blood-Group System</subject><subject>Risk Factors</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Subgroups</subject><subject>Viral infections</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqNk1tr2zAUx83YWLtu32BsgsLoYMl0sSVrLyPNboFAYJe-ClkXR8GxMsku67ef0rglHn0YepB09Dt_nXOkk2UvEZwiwtD7je9DK5vpzrdmCnFJGeWPslPECZ5QDMnjo_VJ9izGDYQFKSl9mp0QhinLITrN1rPLFaga7zWog-93QEYggTadCVvXyrYD3oL56mrxaYI4kK0GS9_WB8sHMGuBr6IJ17JzPgXzDjTp1HW9doedDLUBMe1vnmdPrGyieTHMZ9mvL59_zr9Nlquvi_lsOVGUk26CMTOUElQaqAgkBSUwx6TQUtrcVorhAjJkrUSlRAhRbriuKsYZIoZySCE5y14fdHeNj2IoUhS4xKkaJcYoEYsDob3ciF1wWxluhJdO3Bp8qIUMnVONEQxSwxVntixpjq3lSmuKiCaVQloTnLQ-Drf11dZoZdouyGYkOj5p3VrU_logiAnLOUkKF4NC8L97EzuxdVGZppGt8f1t4IlklOzR83_Qh9MbqFqmDFxrfbpY7UXFjBWowBBSlqjpA1Qa2mydSl_KumQfObwdOSSmM3-6WvYxisWP7__Prq7G7Jsjdm1k062jb_r9h4pjMD-AKvgYg7H3VUZQ7Dvirhpi3xFi6Ijk9ur4he6d7lqA_AXfFQJZ</recordid><startdate>20230602</startdate><enddate>20230602</enddate><creator>Soriano, Joan B</creator><creator>Peláez, Adrián</creator><creator>Busquets, Xavier</creator><creator>Rodrigo-García, María</creator><creator>Pérez-Urría, Elena Ávalos</creator><creator>Alonso, Tamara</creator><creator>Girón, Rosa</creator><creator>Valenzuela, Claudia</creator><creator>Marcos, Celeste</creator><creator>García-Castillo, Elena</creator><creator>Ancochea, Julio</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>COVID</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-9988-4605</orcidid><orcidid>https://orcid.org/0000-0002-4190-6533</orcidid><orcidid>https://orcid.org/0000-0003-0284-6643</orcidid><orcidid>https://orcid.org/0000-0001-9740-2994</orcidid></search><sort><creationdate>20230602</creationdate><title>ABO blood group as a determinant of COVID-19 and Long COVID: An observational, longitudinal, large study</title><author>Soriano, Joan B ; Peláez, Adrián ; Busquets, Xavier ; Rodrigo-García, María ; Pérez-Urría, Elena Ávalos ; Alonso, Tamara ; Girón, Rosa ; Valenzuela, Claudia ; Marcos, Celeste ; García-Castillo, Elena ; Ancochea, Julio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c693t-227e66318e0c30356304235daaf4fbc725071ffa18a11169e9dbb79713e690603</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>ABO Blood-Group System</topic><topic>ABO system</topic><topic>Antibodies</topic><topic>Antigens</topic><topic>Biology and Life Sciences</topic><topic>Blood</topic><topic>Blood groups</topic><topic>Clinical outcomes</topic><topic>Contingency</topic><topic>COVID-19</topic><topic>COVID-19 - epidemiology</topic><topic>Health aspects</topic><topic>Health risks</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>Infections</topic><topic>Long COVID</topic><topic>Longitudinal Studies</topic><topic>Medicine and Health Sciences</topic><topic>Minority & ethnic groups</topic><topic>Multivariate analysis</topic><topic>Pandemics</topic><topic>Physical Sciences</topic><topic>Post-Acute COVID-19 Syndrome</topic><topic>Proteins</topic><topic>Research and Analysis Methods</topic><topic>Rh-Hr Blood-Group System</topic><topic>Risk Factors</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Subgroups</topic><topic>Viral infections</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Soriano, Joan B</creatorcontrib><creatorcontrib>Peláez, Adrián</creatorcontrib><creatorcontrib>Busquets, Xavier</creatorcontrib><creatorcontrib>Rodrigo-García, María</creatorcontrib><creatorcontrib>Pérez-Urría, Elena Ávalos</creatorcontrib><creatorcontrib>Alonso, Tamara</creatorcontrib><creatorcontrib>Girón, Rosa</creatorcontrib><creatorcontrib>Valenzuela, Claudia</creatorcontrib><creatorcontrib>Marcos, Celeste</creatorcontrib><creatorcontrib>García-Castillo, Elena</creatorcontrib><creatorcontrib>Ancochea, Julio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Soriano, Joan B</au><au>Peláez, Adrián</au><au>Busquets, Xavier</au><au>Rodrigo-García, María</au><au>Pérez-Urría, Elena Ávalos</au><au>Alonso, Tamara</au><au>Girón, Rosa</au><au>Valenzuela, Claudia</au><au>Marcos, Celeste</au><au>García-Castillo, Elena</au><au>Ancochea, Julio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ABO blood group as a determinant of COVID-19 and Long COVID: An observational, longitudinal, large study</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2023-06-02</date><risdate>2023</risdate><volume>18</volume><issue>6</issue><spage>e0286769</spage><epage>e0286769</epage><pages>e0286769-e0286769</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>An association of ABO blood group and COVID-19 remains controversial.
Following STROBE guidance for observational research, we explored the distribution of ABO blood group in patients hospitalized for acute COVID-19 and in those with Long COVID. Contingency tables were made and risk factors were explored using crude and adjusted Mantle-Haentzel odds ratios (OR and 95% CI).
Up to September 2022, there were a total of 5,832 acute COVID-19 hospitalizations in our hospital, corresponding to 5,503 individual patients, of whom blood group determination was available for 1,513 (27.5%). Their distribution by ABO was: 653 (43.2%) group 0, 690 (45.6%) A, 113 (7.5%) B, and 57 (3.8%) AB, which corresponds to the expected frequencies in the general population. In parallel, of 676 patients with Long COVID, blood group determination was available for 135 (20.0%). Their distribution was: 60 (44.4%) from group 0, 61 (45.2%) A, 9 (6.7%) B, and 5 (3.7%) AB. The distribution of the ABO system of Long COVID patients did not show significant differences with respect to that of the total group (p ≥ 0.843). In a multivariate analysis adjusting for age, sex, ethnicity, and severity of acute COVID-19 infection, subgroups A, AB, and B were not significantly associated with developing Long COVID with an OR of 1.015 [0.669-1.541], 1.327 [0.490-3.594] and 0.965 [0.453-2.058], respectively. The effect of the Rh+ factor was also not significant 1,423 [0.772-2,622] regarding Long COVID.
No association of any ABO blood subgroup with COVID-19 or developing Long COVID was identified.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>37267401</pmid><doi>10.1371/journal.pone.0286769</doi><tpages>e0286769</tpages><orcidid>https://orcid.org/0000-0002-9988-4605</orcidid><orcidid>https://orcid.org/0000-0002-4190-6533</orcidid><orcidid>https://orcid.org/0000-0003-0284-6643</orcidid><orcidid>https://orcid.org/0000-0001-9740-2994</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1932-6203 |
| ispartof | PloS one, 2023-06, Vol.18 (6), p.e0286769-e0286769 |
| issn | 1932-6203 1932-6203 |
| language | eng |
| recordid | cdi_plos_journals_2821938221 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Free Full-Text Journals in Chemistry; Public Library of Science (PLoS) |
| subjects | ABO Blood-Group System ABO system Antibodies Antigens Biology and Life Sciences Blood Blood groups Clinical outcomes Contingency COVID-19 COVID-19 - epidemiology Health aspects Health risks Hospitalization Humans Infections Long COVID Longitudinal Studies Medicine and Health Sciences Minority & ethnic groups Multivariate analysis Pandemics Physical Sciences Post-Acute COVID-19 Syndrome Proteins Research and Analysis Methods Rh-Hr Blood-Group System Risk Factors Severe acute respiratory syndrome coronavirus 2 Subgroups Viral infections |
| title | ABO blood group as a determinant of COVID-19 and Long COVID: An observational, longitudinal, large study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T04%3A19%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ABO%20blood%20group%20as%20a%20determinant%20of%20COVID-19%20and%20Long%20COVID:%20An%20observational,%20longitudinal,%20large%20study&rft.jtitle=PloS%20one&rft.au=Soriano,%20Joan%20B&rft.date=2023-06-02&rft.volume=18&rft.issue=6&rft.spage=e0286769&rft.epage=e0286769&rft.pages=e0286769-e0286769&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0286769&rft_dat=%3Cgale_plos_%3EA751520067%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2821938221&rft_id=info:pmid/37267401&rft_galeid=A751520067&rft_doaj_id=oai_doaj_org_article_706e9c97f88642ff9cdd613d3bc1dd32&rfr_iscdi=true |